FDA Inspection
Continental Services Group, Inc.Continental Services Group, Inc. – FDA Inspection, Jun 29, 2026
Record Details
This FDA Inspection record concerns Continental Services Group, Inc., with an inspection on June 29, 2026, issued by the Florida District Office, covering biologics.
View Company Profile
ID · 71716b59-b250-45b3-a8f5-e58e89b56e67
Inspection Facts
- Inspection number
- 1326644
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
3- 21 CFR 606.160(a)(1)Person performing, test results, interpretation
- 21 CFR 606.170(a)Adverse Reaction- Reports of Investigations
- 21 CFR 606.60(b)Equipment calibration frequency
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Continental Services Group, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| May 21, 2024 | VAI | Florida District Office | Blood and Blood Products |
| August 24, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| July 9, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 22, 2017 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Continental Services Group, Inc.
- FDA Inspection 1239104 - 2024-05-21
- FDA Inspection 1178110 - 2022-08-24
- FDA Inspection 1096414 - 2019-07-09
- FDA Inspection 1023396 - 2017-08-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.